Trajan Scientific Australia

Trajan Scientific Australia

The entity is incorporated as Trajan Scientific Australia Pty Ltd and serves as the private investment vehicle for the family controlling the Trajan Group, an Australian manufacturer of analytical chemistry and medical components. The operating business was founded in 2012 and listed on the ASX in 2018 under the ticker TRJ, generating the family's wealth. The family office structure handles the proceeds and reinvestment. Investment strategy details are not publicly available. Trajan Group itself focuses on precision components for mass spectrometry, chromatography, and blood-collection devices. The family office's asset allocation, stage focus, and geographic footprint are not disclosed. No named portfolio companies, co-investors, or third-party mandates have been identified. No team size, professional names, or additional office locations are verifiable through public record. The family office may share directors or executives with Trajan Group, but those relationships are not formally documented. No philanthropic foundation or operating subsidiary under the family office name has been reported. The structural differentiator is the entity's close tie to a single operating company that underwent a public listing, creating a capital base for management outside the parent business. This architecture — where the family office is incorporated in the same jurisdiction as the operating company—mirrors other Australian entrepreneurial family offices that emerged from an IPO event (per public record).